Xia 3
Device Thoracolumbar
PDI 04546540561107
General payments
$1,436,186
Research payments
$47,170
Through program year 2025, $1,436,186 in general payments and $47,170 in research payments were reported against Xia 3 (Thoracolumbar).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $62,719 | 56 |
| 2024 | General | $98,350 | 251 |
| 2024 | Research | $47,170 | 8 |
| 2023 | General | $178,638 | 449 |
| 2022 | General | $215,381 | 470 |
| 2021 | General | $881,099 | 523 |
Breakdown
The top 5 of 36 recipients; each share is of general payments naming this product in 2025.
The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 14 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,749 general · 8 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.